{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:40Z","timestamp":1792807120089,"version":"4.5.0"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1248\/bpb.b19-01050","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T22:05:09Z","timestamp":1583445909000},"page":"839-847","source":"Crossref","is-referenced-by-count":4,"title":["Ethenzamide Exerts Analgesic Effect at the Spinal Cord <i>via<\/i> Multiple Mechanisms of Action Including the 5HT<sub>2B<\/sub> Receptor Blockade in the Rat Formalin Test"],"prefix":"10.1248","volume":"43","author":[{"given":"Takato","family":"Nikaido","sequence":"first","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Hamanaka","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Fujimaru","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Asano","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Takaoka","sequence":"additional","affiliation":[{"name":"Self-medication R&D laboratories, Taisho Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Tsukuda Y, Tsutsui M, Ono T, Nikaido T, Hamanaka M, Kijima H, Asano T, Mizutani R, Mizuma Y, Inohara T, Kanazawa M, Watanabe K. Safety and effectiveness for OTC antipyretic \u201cNARON ACE\u00ae<\/sup>. Jpn. J. Med. Pharm. Sci.<\/i>, 68<\/b>, 663\u2013674 (2012)."},{"key":"2","unstructured":"2) Okuyama S, Tachikawa S, Aihara H, Kameyama T. Studies on the combined analgesic effect of ibuprofen and antipyretic analgesic drugs. Jpn. Pharmacol. Ther.<\/i>, 18<\/b>, 3359\u20133603 (1990)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsui T. Effects of ethenzamide on spinal reflex potentials in cats. Jap. J. Oral Biol.<\/i>, 20<\/b>, 581\u2013590 (1978).","DOI":"10.2330\/joralbiosci1965.20.581"},{"key":"4","unstructured":"4) Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain<\/i>, 152<\/b> (Suppl.), S2\u2013S15 (2011)."},{"key":"5","unstructured":"5) Hylden JL, Nahin RL, Traub RJ, Dubner R. Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain<\/i>, 37<\/b>, 229\u2013243 (1989)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science<\/i>, 278<\/b>, 275\u2013279 (1997).","DOI":"10.1126\/science.278.5336.275"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pacharinsak C, Khasabov SG, Beitz AJ, Simone DA. NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin. Pain<\/i>, 139<\/b>, 34\u201346 (2008).","DOI":"10.1016\/j.pain.2008.02.032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, J\u00e4ger T, Sandk\u00fchler J. Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science<\/i>, 312<\/b>, 1659\u20131662 (2006).","DOI":"10.1126\/science.1127233"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Cao Y, Wang H, Chiang CY, Dostrovsky JO, Sessle BJ. Pregabalin suppresses nociceptive behavior and central sensitization in a rat trigeminal neuropathic pain model. J. Pain<\/i>, 14<\/b>, 193\u2013204 (2013).","DOI":"10.1016\/j.jpain.2012.11.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT1B\/1D<\/sub> receptor agonists. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 101<\/b>, 4274\u20134279 (2004).","DOI":"10.1073\/pnas.0306147101"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Marciszewski KK, Meylakh N, Di Pietro F, Mills EP, Macefield VG, Macey PM, Henderson LA. Changes in brainstem pain modulation circuitry function over the migraine cycle. J. Neurosci.<\/i>, 38<\/b>, 10479\u201310488 (2018).","DOI":"10.1523\/JNEUROSCI.1088-18.2018"},{"key":"12","unstructured":"12) Dirig DM, Yaksh TL. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J. Pharmacol. Exp. Ther.<\/i>, 275<\/b>, 219\u2013227 (1995)."},{"key":"13","unstructured":"13) Wheeler-Aceto H, Porreca F, Cowan A. The rat paw formalin test: comparison of noxious agents. Pain<\/i>, 40<\/b>, 229\u2013238 (1990)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM. TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 104<\/b>, 13525\u201313530 (2007).","DOI":"10.1073\/pnas.0705924104"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Dickenson AH, Sullivan AF. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett.<\/i>, 83<\/b>, 207\u2013211 (1987).","DOI":"10.1016\/0304-3940(87)90242-4"},{"key":"16","unstructured":"16) Tj\u00f8lsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain<\/i>, 51<\/b>, 5\u201317 (1992)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) McCarson KE, Goldstein BD. Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat. Brain Res.<\/i>, 568<\/b>, 109\u2013115 (1991).","DOI":"10.1016\/0006-8993(91)91385-E"},{"key":"18","unstructured":"18) Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol.<\/i>, 112<\/b>, 547\u2013550 (1994)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hunskaar S, Berge OG, Hole K. Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain<\/i>, 25<\/b>, 125\u2013132 (1986).","DOI":"10.1016\/0304-3959(86)90014-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mallet C, Barri\u00e8re DA, Ermund A, J\u00f6nsson BA, Eschalier A, Zygmunt PM, H\u00f6gest\u00e4tt ED. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS ONE<\/i>, 5<\/b>, e12748 (2010).","DOI":"10.1371\/journal.pone.0012748"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lin SY, Chang WJ, Lin CS, Huang CY, Wang HF, Sun WH. Serotonin receptor 5-HT2B<\/sub> mediates serotonin-induced mechanical hyperalgesia. J. Neurosci.<\/i>, 31<\/b>, 1410\u20131418 (2011).","DOI":"10.1523\/JNEUROSCI.4682-10.2011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Aira Z, Buesa I, Garc\u00eda del Ca\u00f1o G, Salgueiro M, Mendiable N, Mingo J, Aguilera L, Bilbao J, Azkue JJ. Selective impairment of spinal mu-opioid receptor mechanism by plasticity of serotonergic facilitation mediated by 5-HT2A<\/sub> and 5-HT2B<\/sub> receptors. Pain<\/i>, 153<\/b>, 1418\u20131425 (2012).","DOI":"10.1016\/j.pain.2012.03.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Cervantes-Dur\u00e1n C, Vidal-Cant\u00fa GC, Barrag\u00e1n-Iglesias P, Pineda-Farias JB, Bravo-Hern\u00e1ndez M, Murbarti\u00e1n J, Granados-Soto V. Role of peripheral and spinal 5-HT2B<\/sub> receptors in formalin-induced nociception. Pharmacol. Biochem. Behav.<\/i>, 102<\/b>, 30\u201335 (2012).","DOI":"10.1016\/j.pbb.2012.03.015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Cervantes-Dur\u00e1n C, Vidal-Cant\u00fa GC, God\u00ednez-Chaparro B, Granados-Soto V. Role of spinal 5-HT2<\/sub> receptors subtypes in formalin-induced long-lasting hypersensitivity. Pharmacol. Rep.<\/i>, 68<\/b>, 434\u2013442 (2016).","DOI":"10.1016\/j.pharep.2015.11.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Pineda-Farias JB, Vel\u00e1zquez-Lagunas I, Barrag\u00e1n-Iglesias P, Cervantes-Dur\u00e1n C, Granados-Soto V. 5-HT2B<\/sub> receptor antagonists reduce nerve injury-induced tactile allodynia and expression of 5-HT2B<\/sub> receptors. Drug Dev. Res.<\/i>, 76<\/b>, 31\u201339 (2015).","DOI":"10.1002\/ddr.21238"},{"key":"26","unstructured":"26) Aira Z, Buesa I, Garc\u00eda del Ca\u00f1o G, Bilbao J, Do\u00f1ate F, Zimmermann M, Azkue JJ. Transient, 5-HT2B<\/sub> receptor-mediated facilitation in neuropathic pain: Up-regulation of PKC\u03b3 and engagement of the NMDA receptor in dorsal horn neurons. Pain<\/i>, 154<\/b>, 1865\u20131877 (2013)."},{"key":"27","unstructured":"27) Bonhaus DW, Flippin LA, Greenhouse RJ, Jaime S, Rocha C, Dawson M, Van Natta K, Chang LK, Pulido-Rios T, Webber A, Leung E, Eglen RM, Martin GR. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B<\/sub> receptor antagonist. Br. J. Pharmacol.<\/i>, 127<\/b>, 1075\u20131082 (1999)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Audia JE, Evrard DA, Murdoch GR, Droste JJ, Nissen JS, Schenck KW, Fludzinski P, Lucaites VL, Nelson DL, Cohen ML. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B<\/sub> (5HT2B<\/sub>) contractile receptor in the rat stomach fundus. J. Med. Chem.<\/i>, 39<\/b>, 2773\u20132780 (1996).","DOI":"10.1021\/jm960062t"},{"key":"29","unstructured":"29) Forbes IT, Jones GE, Murphy OE, Holland V, Baxter GS. N<\/i>-(1-methyl-5-indolyl)-N<\/i>\u2032-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B<\/sub> receptor antagonist. J. Med. Chem.<\/i>, 38<\/b>, 855\u2013857 (1995)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Shibasaki J, Konishi R, Takemura M, Fukushima E, Nakamura J, Sasaki H. Comparison of the first-pass metabolism of ethenzamide and salicylamide in rats. J. Pharmacobiodyn.<\/i>, 7<\/b>, 804\u2013810 (1984).","DOI":"10.1248\/bpb1978.7.804"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mifflin KA, Benson C, Thorburn KC, Baker GB, Kerr BJ. Manipulation of neurotransmitter levels has differential effects on formalin-evoked nociceptive behavior in male and female mice. J. Pain<\/i>, 17<\/b>, 483\u2013498 (2016).","DOI":"10.1016\/j.jpain.2015.12.013"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Potter LE, Doolen S, Mifflin K, Tenorio G, Baker G, Taylor BK, Kerr BJ. Antinociceptive effects of the antidepressant phenelzine are mediated by context-dependent inhibition of neuronal responses in the dorsal horn. Neuroscience<\/i>, 383<\/b>, 205\u2013215 (2018).","DOI":"10.1016\/j.neuroscience.2018.04.047"},{"key":"33","unstructured":"33) Kanai Y, Hara T, Imai A. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin. J. Pharm. Pharmacol.<\/i>, 58<\/b>, 489\u2013493 (2006)."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shutov LP, Warwick CA, Shi X, Gnanasekaran A, Shepherd AJ, Mohapatra DP, Woodruff TM, Clark JD, Usachev YM. The complement system component C5a produces thermal hyperalgesia via<\/i> macrophage-to-nociceptor signaling that requires NGF and TRPV1. J. Neurosci.<\/i>, 36<\/b>, 5055\u20135070 (2016).","DOI":"10.1523\/JNEUROSCI.3249-15.2016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B<\/sub> receptor activation. Cephalalgia<\/i>, 23<\/b>, 117\u2013123 (2003).","DOI":"10.1046\/j.1468-2982.2003.00464.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Schmitz B, Ullmer C, Segelcke D, Gwarek M, Zhu XR, L\u00fcbbert H. BF-1-a novel selective 5-HT2B<\/sub> receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs. Eur. J. Pharmacol.<\/i>, 751<\/b>, 73\u201380 (2015).","DOI":"10.1016\/j.ejphar.2015.01.043"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Segelcke D, Messlinger K. Putative role of 5-HT2B<\/sub> receptors in migraine pathophysiology. Cephalalgia<\/i>, 37<\/b>, 365\u2013371 (2017).","DOI":"10.1177\/0333102416646760"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:32:53Z","timestamp":1588833173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-01050","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}